Prevalence of pulmonary arterial hypertension in patients with connective tissue diseases: A systematic review of the literature

Clinical Rheumatology

Volumn 32, Issue 10, 2013, Pages 1519-1531

  Yang, Xiaoqin ^a,b   Mardekian, Jack ^c   Sanders, Kafi N ^c   Mychaskiw, Marko A ^c   Thomas III, Joseph ^a,b  

^a PURDUE UNIVERSITY   (United States)

^b Purdue University   (United States)

^c PFIZER INC   (United States)

Author keywords

Connective tissue diseases; Prevalence; Pulmonary hypertension; Review

Indexed keywords

ARTICLE; CONNECTIVE TISSUE DISEASE; DERMATOMYOSITIS; ECHOCARDIOGRAPH; HEART CATHETERIZATION; HUMAN; IDIOPATHIC DISEASE; POLYMYOSITIS; PREVALENCE; PRIORITY JOURNAL; PUBLICATION; PULMONARY HYPERTENSION; RHEUMATOID ARTHRITIS; SJOEGREN SYNDROME; SYSTEMATIC REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS;

ARTHRITIS, RHEUMATOID; CARDIAC CATHETERIZATION; COMORBIDITY; CONNECTIVE TISSUE DISEASES; HUMANS; HYPERTENSION, PULMONARY; LUPUS ERYTHEMATOSUS, SYSTEMIC; PREVALENCE; SCLERODERMA, SYSTEMIC;

EID: 84885298165     PISSN: 07703198     EISSN: 14349949     Source Type: Journal    
DOI: 10.1007/s10067-013-2307-2     Document Type: Article

References (42)

1. McLaughlin VV, ACCF/AHA, et al. (2009) Expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American College of Chest Physicians; American Thoracic Society, Inc.; and the Pulmonary Hypertension Association. J Am Coll Cardiol 53(17):1573-1619
2. Gaine SP, Rubin LJ (1998) Primary pulmonary hypertension. Lancet 352(9129):719-725
3. Baughman RP, Carbone, RG, Bottino G (2009) Pulmonary arterial hypertension and interstitial lung diseases: a clinical guide. R.G.C. Robert P. Baughman, Giovanni Bottino (ed) Humana Press: New York, NY
4. Kimberly (2001) Primer on the rheumatic diseases. J.H. Klippel (ed) Arthritis Foundation: Atlanta, GA. p. 325-8
5. Trell E, Lindstrom C (1971) Pulmonary hypertension in systemic sclerosis. Ann Rheum Dis 30(4):390-400
6. Perez HD, Kramer N (1981) Pulmonary hypertension in systemic lupus erythematosus: report of four cases and review of the literature. Semin Arthritis Rheum 11(1):177-181
7. Sullivan WD, et al. (1984) A prospective evaluation emphasizing pulmonary involvement in patients with mixed connective tissue disease. Med (Baltimore) 63(2):92-107
8. Wiener-Kronish JP, et al. (1981) Severe pulmonary involvement in mixed connective tissue disease. Am Rev Respir Dis 124(4):499-503
9. Galie N, et al. (2005) Pulmonary arterial hypertension associated to connective tissue diseases. Lupus 14(9):713-717
10. Peacock AJ, et al. (2007) An epidemiological study of pulmonary arterial hypertension. Eur Respir J 30(1):104-109
11. Humbert M, et al. (2006) Pulmonary arterial hypertension in France: results from a national registry. Am J Respir Crit Care Med 173(9):1023-1030
12. Tueller C, et al. (2008) Epidemiology of pulmonary hypertension: new data from the Swiss registry. Swiss Med Wkly 138(25-26):379-384
13. Higgins JPT, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21:1539-1558
14. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7(3):177-188
15. McGoon M, et al. (2004) Screening, early detection, and diagnosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest 126(1 Suppl):14S-34S
16. Denton CP, et al. (1997) Comparison of Doppler echocardiography and right heart catheterization to assess pulmonary hypertension in systemic sclerosis. Br J Rheumatol 36(2):239-243
17. Humbert M, et al. (2011) Screening for pulmonary arterial hypertension in patients with systemic sclerosis: clinical characteristics at diagnosis and long-term survival. Arthritis Rheum 63(11):3522-3530
18. Meune C, et al. (2011) Prediction of pulmonary hypertension related to systemic sclerosis by an index based on simple clinical observations. Arthritis Rheum 63(9):2790-2796
19. Hachulla E, et al. (2005) Early detection of pulmonary arterial hypertension in systemic sclerosis: a French nationwide prospective multicenter study. Arthritis Rheum 52(12):3792-3800
20. Hachulla E, et al. (2009) Risk factors for death and the 3-year survival of patients with systemic sclerosis: the French ItinerAIR-Sclerodermie study. Rheumatology (Oxford) 48(3):304-308
21. Avouac J, et al. (2010) Prevalence of pulmonary hypertension in systemic sclerosis in European Caucasians and metaanalysis of 5 studies. J Rheumatol 37(11):2290-2298
22. Vonk MC, et al. (2009) Systemic sclerosis and its pulmonary complications in The Netherlands: an epidemiological study. Ann Rheum Dis 68(6):961-965
23. Phung S, et al. (2009) Prevalence of pulmonary arterial hypertension in an Australian scleroderma population: screening allows for earlier diagnosis. Int Med J 39(10):682-691
24. de Azevedo AB, et al. (2005) Prevalence of pulmonary hypertension in systemic sclerosis. Clin Exp Rheumatol 23(4):447-454
25. Coral-Alvarado P, et al. (2008) Risk factors associated with pulmonary arterial hypertension in Colombian patients with systemic sclerosis: review of the literature. J Rheumatol 35(2):244-250
26. Kumar U, et al. (2008) Prevalence and predictors of pulmonary artery hypertension in systemic sclerosis. J Assoc Phys India 56:413-417
27. Pope JE, et al. (2005) Prevalence of elevated pulmonary arterial pressures measured by echocardiography in a multicenter study of patients with systemic sclerosis. J Rheumatol 32(7):1273-1278
28. Gindzienska-Sieskiewicz E, et al. (2005) The occurrence of pulmonary hypertension in patients with systemic sclerosis hospitalized in the Department of Rheumatology and Internal Diseases Medical University of Bialystok in years 2003-2004. Rocz Akad Med Bialymst 50(Suppl 1):297-300
29. Chang B, et al. (2003) Scleroderma patients with combined pulmonary hypertension and interstitial lung disease. J Rheumatol 30(11):2398-2405
30. Yamane K, et al. (2000) Clinical and laboratory features of scleroderma patients with pulmonary hypertension. Rheumatology (Oxford) 39(11):1269-1271
31. Pan TL, Thumboo J, Boey ML (2000) Primary and secondary pulmonary hypertension in systemic lupus erythematosus. Lupus 9(5):338-342
32. Prabu A, et al. (2009) Prevalence and risk factors for pulmonary arterial hypertension in patients with lupus. Rheumatology (Oxford) 48(12):1506-1511
33. Dawson JK, et al. (2000) Raised pulmonary artery pressures measured with Doppler echocardiography in rheumatoid arthritis patients. Rheumatology (Oxford) 39(12):1320-1325
34. Keser G, et al. (2004) Pulmonary hypertension in rheumatoid arthritis. Scand J Rheumatol 33(4):244-245
35. Wigley FM, et al. (2005) The prevalence of undiagnosed pulmonary arterial hypertension in subjects with connective tissue disease at the secondary health care level of community-based rheumatologists (the UNCOVER study). Arthritis & Rheumatism 52(7):2125-2132
36. Gavaghan DJ, Moore RA, McQuay HJ (2000) An evaluation of homogeneity tests in meta-analyses in pain using simulations of individual patient data. Pain 85(3):415-424
37. Hatano S, Strasser T, WH Organization (1975) Primary pulmonary hypertension: report on a WHO meeting: World Health Organization, Geneva
38. Badesch DB, et al. (2009) Diagnosis and assessment of pulmonary arterial hypertension. J Am Coll Cardiol 54(1 Suppl):S55-S66
39. Kovacs G, et al. (2009) Pulmonary arterial pressure during rest and exercise in healthy subjects: a systematic review. Eur Respir J 34(4):888-894
40. Galie N, et al. (2004) Guidelines on diagnosis and treatment of pulmonary arterial hypertension. The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology. Eur Heart J 25(24):2243-2278
41. Condliffe R, et al. (2009) Connective tissue disease-associated pulmonary arterial hypertension in the modern treatment era. Am J Respir Crit Care Med 179(2):151-157
42. Chung L, et al. (2010) Characterization of connective tissue disease-associated pulmonary arterial hypertension from REVEAL: identifying systemic sclerosis as a unique phenotype. Chest 138(6):1383-1394